Cited by 583Atrial Fibrillation Management and OutcomesCardiac Fibrosis and RemodelingCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

Open access

Goette, Andreas, Staack, Thorsten, Röcken, Christoph, Arndt, Marco, Geller, J.Christoph, Huth, Christof, Ansorge, Siegfried, Klein, Helmut U, Lendeckel, Uwe·2000·Journal of the American College of Cardiology

DOI 10.1016/s0735-1097(00)00611-2

Open this paper in CoChat — free account Open PDF

Abstract

Objectives The purpose of this study was to determine whether atrial expression of the extracellular signal-regulated kinases Erk1/Erk2 and of the angiotensin-converting enzyme (ACE) is altered in patients with atrial fibrillation (AF).Background Recent studies have demonstrated that atrial fibrosis can provide a pathophysiologic substrate for AF. However, the molecular mechanisms responsible for the development of atrial fibrosis are unclear.Methods Atrial tissue samples of 43 patients undergoing open heart surgery were examined. Seventeen patients had chronic persistent AF (> or =6 months; CAF), 8 patients had paroxysmal AF (PAF) and 18 patients had no history of AF. Erk expression was analyzed at the mRNA (quantitative reverse transcription polymerase chain reaction), the protein (immunoblot techniques) and atrial tissue (immunohistochemistry) levels. Erk-activating kinases (MEK1/2) and ACE were analyzed by immunoblot techniques.Results Increased amounts of Erk2-mRNA were found in patients with CAF (75 +/- 20 U vs. sinus rhythm: 31 +/- 25 U; p < 0.05). Activated Erk1/Erk2 and MEK1/2 were increased to more than 150% in patients with AF compared to patients with sinus rhythm. No differences between CAF and PAF were found. The expression of ACE was three-fold increased during CAF. Amounts of activated Erk1/Erk2 were reduced in patients treated with ACE inhibitors. Patients with AF showed an increased expression of Erk1/Erk2 in interstitial cells and marked atrial fibrosis.Conclusions An ACE-dependent increase in the amounts of activated Erk1/Erk2 in atrial interstitial cells may contribute as a molecular mechanism for the development of atrial fibrosis in patients with AF. These findings may have important impact on the treatment of AF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(00)00611-2

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Atrial Fibrillation Begets Atrial Fibrillation
WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,035
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation
Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1180 · Cited by 1,400
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
Chronic Rapid Atrial Pacing
Morillo, C. A., Klein, G. J., Jones, D. L., & Guiraudon, C. M. (1995) · Circulation · doi:10.1161/01.cir.91.5.1588 · Cited by 1,046
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.
Sanfilippo, A. J., Abascal, V. M., Sheehan, M., Oertel, L. B., Harrigan, P., Hughes, R. A., & Weyman, A. E. (1990) · Circulation · doi:10.1161/01.cir.82.3.792 · Cited by 739 · cited 2×
“In addition, it is well known that persistent AF, as found in our patient population, is accompanied by a significant dilation of the atria (3,22).”
Background
Structural Changes of Atrial Myocardium due to Sustained Atrial Fibrillation in the Goat
Ausma, J., WIJFFELS, M. C. E. F., Thoné, F., Wouters, L., Allessie, M. A., & Borgers, M. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.3157 · Cited by 669
Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction
Pedersen, O. D., Bagger, H., Køber, L., & Torp-Pedersen, C. T. (1999) · Circulation · doi:10.1161/01.cir.100.4.376 · Cited by 656

Show all 47 references

Research works printed but not linked: 1

Goette, 1999, Atrial expression of pro- inflammatory cytokines during chronic atrial fibrillation in humans, PACE, 22, A117

Sorted by citations

Items 401–500 of 576

Left Atrial Volume and Post-Operative Atrial Fibrillation after Aortic Valve Replacement.
Reddy, Y. M., Satpathy, R., Shen, X., Holmberg, M. J., Hunter, C. B., Mooss, A. N., & Esterbrooks, D. J. (2010) · Europe PMC (PubMed Central) · doi:10.4022/jafib.338 · Cited by 6
Effect of Atrial Fibrillation on Contrast-Induced Nephropathy Development in Patients With Non-ST-Segment Elevation Myocardial Infarction
Düzel, B., Emren, S. V., & Berılğen, R. (2017) · Angiology · doi:10.1177/0003319717699328 · Cited by 6
Atrial Calpains: Mediators of Atrialmyopathies in Atrial Fibrillation.
Bukowska, A., Lendeckel, U., & Goette, A. (2014) · PubMed Central · doi:10.4022/jafib.1021 · Cited by 6
Atrial Fibrillation Genetic Considerations: The Basic Scientist's Perspective
Wang, Q. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-163-5_10 · Cited by 6
AT 1 mutations and risk of atrial fibrillation based on genotypes from 71 000 individuals from the general population
Marott, S. C. W., Nordestgaard, B. G., Jensen, G. B., Tybjærg‐Hansen, A., & Benn, M. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12050 · Cited by 6
Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation
Liu, C., Liu, T., & Li, G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.037 · Cited by 6
Prevención de la fibrilación auricular en el paciente hipertenso
Alonso, V. B., von Wichmann, M. D. L. F., & Payeras, A. C. (2007) · Medicina Clínica · doi:10.1157/13098021 · Cited by 6
Cardiac Near-Field Morphology During Conduction Around a Microscopic Obstacle—A Computer Simulation Study
Plank, G., Vigmond, E. J., Leon, L. J., & Hofer, E. (2003) · Annals of Biomedical Engineering · doi:10.1114/1.1615573 · Cited by 6
Angiotensin converting enzyme and the arrhythmogenic action of angiotensin I: cardiac cell membrane as a site of angiotensin I conversion
Mello, W. C. D. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.008 · Cited by 6
Tachycardia-induced remodeling: atria and ventricles take a different route
GOETTE, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.005 · Cited by 6
Electric Cardioversion in Older Adults. Is Sedation Using Propofol Safe in the Absence of the Direct Anesthetist's Assistance?
Karwowski, J., Wrzosek, K., Rekosz, J., Tymoszuk, K., Wiktorska, A., Szmarowska, K., Solecki, M., & Dłużniewski, M. (2024) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484231221929 · Cited by 5
Postoperative Atrial Fibrillation Prediction by Left Atrial Size in Coronary Artery Bypass Grafting and Five-Year Survival Outcome
Gerçek, M., Börgermann, J., Gummert, J. F., & Gerçek, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133738 · Cited by 6
Left Atrial Low-Voltage Zone Assessment and Voltage-Guided Ablation Outcome in Patients With Atrial Fibrillation-Induced Tachycardiomyopathy
Marzak, H., Hammann, J., Matsushita, K., Ringele, R., Fitouchi, S., Séverac, F., Cardi, T., Kanso, M., Schatz, A., Ohlmann, P., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-24-0079 · Cited by 5
Shedding new light on the pathophysiology of conversion of paroxysmal atrial fibrillation into persistent atrial fibrillation
Homoud, M. K., & Estes, M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.017 · Cited by 5
Atrial Fibrillation in the Elderly
Fischer, G. W. (2009) · Anesthesiology Clinics · doi:10.1016/j.anclin.2009.07.006 · Cited by 5
Protective Effects of Aliskiren on Atrial Ionic Remodeling in a Canine Model of Rapid Atrial Pacing
Zhao, Z., Wang, X., Li, J., Yang, W., Cheng, L., Chen, Y., Liu, T., Liu, E., Chen, K., & Li, G. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6509-x · Cited by 5
Novel pharmacological therapies for atrial fibrillation
Bagwe, S., Leonardi, M., & Bissett, J. K. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328204c45b · Cited by 5
Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation
Wang, Q., Zhang, X.-D., Liu, X., & Yang, Y. (2016) · Herz · doi:10.1007/s00059-015-4371-7 · Cited by 5
Chronic kidney disease is independently associated with acute recurrent cerebral infarct in patients with atrial fibrillation
Sakuta, K., Iguchi, Y., Sato, T., Sakai, K., Terasawa, Y., & Mitsumura, H. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.02.013 · Cited by 5
Electrical and histological remodeling of the pulmonary vein in 2K1C hypertensive rats: Indication of initiation and maintenance of atrial fibrillation
Xia, P.-P. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7844 · Cited by 5
The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation
Jia, Q., Han, W., Shi, S., & Hu, Y. (2021) · Medicine · doi:10.1097/md.0000000000024280 · Cited by 5
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation
Wachtell, K., Devereux, R. B., & Lyle, P. A. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0075-1 · Cited by 5
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
Palardy, M., & Ducharme, A. (2005) · Heart Drug · doi:10.1159/000089602 · Cited by 5
The effect of angiotensin receptor blockers for preventing atrial fibrillation
Wachtell, K., Devereux, R. B., & Lyle, P. A. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0051-1 · Cited by 5
Rhythm Association and the Heart Rhythm Society Developed in Collaboration With the European Heart Atrial Fibrillation): Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiology Committee for Practice Guidelines (Writing Cardiology/American Heart Association Task Force on Practice Guidelines and Fibrillation—Executive Summary: A Report of the American College of ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial
Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, L., Despres, C., Dickstein, K., Lekakis, J. P., McGregor, K., Metra, M., Budaj, A., et al. (2006) · Cited by 5
Renin-Angiotensin System and AtrialFibrillation:Understanding the Connection.
Disertori, M., & Quintarelli, S. (2011) · Europe PMC (PubMed Central) · doi:10.4022/jafib.398 · Cited by 5
Hypertensive Folgeschäden am Herzen
Steinmetz, M., & Nickenig, G. (2009) · Der Internist · doi:10.1007/s00108-008-2289-3 · Cited by 5
Molecular Mechanisms of Remodeling in Human Atrial Fibrillation
Brundel, B. J. J. M., Henning, R. H., Kampinga, H. H., Gelder, I. C. V., & Crijns, H. J. G. M. (2002) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-1005-5_17 · Cited by 5
The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation
Goette, A. (2011) · EP Europace · doi:10.1093/europace/eur045 · Cited by 5
Relationship Between the Long-Term Preventive Effect of Combined Treatment With Antiarrhythmic Drugs Plus Angiotensin-Converting Enzyme Inhibitors and Circadian Variation in the Onset of Paroxysmal Atrial Fibrillation
Komatsu, T., Tachibana, H., Satoh, Y., Ozawa, M., Kunugida, F., & Nakamura, M. (2010) · International Heart Journal · doi:10.1536/ihj.51.331 · Cited by 4
New therapeutic targets for ACE inhibitors and angiotensin receptor blockers
Dimitrow, P. P. (2012) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.115 · Cited by 4
Association between elevated plasma aldosterone concentration and left atrial conduit function in hypertension
Zhang, S., Gao, X., Wang, D., Jiang, Y., & Liu, Y. (2019) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2019.100015 · Cited by 4
Quantifying Risk Factors for Atrial Fibrillation: Retrospective Review of a Large Electronic Patient Database
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2365 · Cited by 4
Prevalence and Impact of Atrial Fibrillation on Prognosis in Takotsubo Cardiomyopathy Patients
Koniari, I. C., Papageorgiou, A., Artopoulou, E., Velissaris, D., Mplani, V., Kounis, N. G., Hahalis, G. N., & Tsigkas, G. (2022) · Angiology · doi:10.1177/00033197221079331 · Cited by 4
Non-antiarrhythmic medications for atrial fibrillation: From bench to clinical practice
Guglin, M. E., Garcia, M., Yarnoz, M. J., & Curtis, A. B. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9204-7 · Cited by 4
Inhibition of Inward Rectifier K+ Currents by Angiotensin II in Rat Atrial Myocytes: Lack of Effects in Cells from Spontaneously Hypertensive Rats
Sonoyama, K., Ninomiya, H., Igawa, O., Kaetsu, Y., Furuse, Y., Hamada, T., Miake, J., Li, P., Yamamoto, Y., Oginö, K., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.923 · Cited by 4
Atrial fibrillation: Pathophysiology and current therapy
Miyazaki, S., Shah, A. J., Scherr, D., & Haı̈ssaguerre, M. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.554426 · Cited by 4
Atrial Remodelling : Role in Atrial Fibrillation Ablation.
Grubitzsch, H., & Haverkamp, W. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.691 · Cited by 4
Left Atrial Size Is a Poor Predictor of Pathology in the Older Patient: Preliminary Observations
Goldman, J. H., Ehlgen, A., Ursell, P. C., & Schiller, N. B. (2006) · Echocardiography · doi:10.1111/j.1540-8175.2006.00174.x · Cited by 4
Neue Aspekte in der Therapie des Vorhofflimmerns
Ravens, U., Dobrev, D., & Goette, A. (2006) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-006-0511-3 · Cited by 4
Titin cleavage is a driver of cardiomyocyte disengagement and reactive myocardial fibrosisPreprint
López-Unzu, M. Á., Pricolo, M. R., Silva‐Rojas, R., Clemente-Manteca, A., Sánchez-Ortiz, D., Vicente, N., Velázquez-Carreras, D., Morales, C., Gavilán-Herrera, M., Sen-Martín, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.645683 · Cited by 4
Safety and efficacy of anticoagulant administration in people with atrial fibrillation and advanced chronic kidney disease
Irlik, K., Kwiendacz, H., Ignacy, W., Grabska, A., Gumprecht, J., Lip, G. Y. H., & Nabrdalik, K. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2574492 · Cited by 3
Conformational fingerprinting of angiotensin-converting enzyme in the blood in health and disease
Kost, O. A., Petrov, M. N., Naperova, I. A., Tikhomirova, V. E., Kryukova, O. V., Владимировна, Г. И., Bulaeva, N. I., Golukhova, E. Z., & Danilov, S. M. (2016) · Moscow University Chemistry Bulletin · doi:10.3103/s0027131416010089 · Cited by 3
Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series
Velasco, E. B., de la Flor, J. C., de la Manzanara, V. L., y, L. N.-F., Narváez-Mejía, C., Vega, L. L. C., Villa, D. E., Zamora, R., Tapia, M., Sastre, M. Á., et al. (2024) · Medicina · doi:10.3390/medicina60020231 · Cited by 3
Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients
Mahadevan, A., Garikipati, S., Vanani, S., Sundaram, D. M., Thompson‐Edwards, A., Reyaz, N., Babu, K., Rajarajan, S., Dhavapalani, D., Anand, D. P., et al. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.07.016 · Cited by 3
[Effects of renal sympathetic denervation on inducibility of atrial fibrillation during rapid atrial pacing].
Zou, M., Zhao, Q., Yu, S., Dai, Z.-X., Wang, X., Xiao, J., Yang, B., & Huang, C.-X. (2012) · PubMed · Cited by 3
Atrial Fibrillation – An Orchestra of Classic and Modern Risk Factors
Balan, A. I., & Scridon, A. (2019) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2019-0020 · Cited by 3
Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types
Doğan, A., Gedikli, Ö., Özaydın, M., & Acar, G. (2010) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2010.089 · Cited by 3
Angiotensin II receptor blockers in the prevention of atrial fibrillation
Barra, S., Silvestri, N., Vitagliano, G., Madrid, A., & Gaeta, G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902973736 · Cited by 3
Effects of Systolic Atrial Function on Plasma Renin Activity and Natriuretic Peptide Secretion after High Rate Atrial and Ventricular Pacing in Dogs
Zupan, I., Krhin, B., Breskvar, U., Zupan, I. P., & Rakovec, P. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00080.x · Cited by 3
Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: long-term echocardiographic study
Fukuda, Y., Fukuda, N., Morishita, S., & Tamura, Y. (2011) · European Journal of Echocardiography · doi:10.1093/ejechocard/jeq193 · Cited by 3
Future Directions in Antiarrhythmic Drug Therapy for Atrial Fibrillation
Musco, S., Seltzer, J. H., & Kowey, P. R. (2006) · Future Cardiology · doi:10.2217/14796678.2.5.545 · Cited by 3
Determination of vessel size: a putative framework to assess clinical outcome
Asselbergs, F. W., Piers, L. H., Jessurun, G. A. J., Boven, A. J. V., Veeger, N. J. G. M., Zijlstra, F., van Gilst, W. H., & Tio, R. A. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.037 · Cited by 3
Repeat Catheter Ablation of Long-standing Persistent Atrial Fibrillation in Patients with a Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the CHA2DS2-VASc Score and Estimated Glomerular Filtration Rate on the Outcomes
Wang, Q., Jiang, S.-L., Liu, X., & Yang, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5790 · Cited by 3
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
Eide, S. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7616 · Cited by 3
Atrial Fibrillation: Experimental and Theoretical Developments
Nattel, S. (2001) · Cardiac Electrophysiology Review · doi:10.1023/a:1011413723731 · Cited by 3
The three-dimensional substrate of atrial fibrillation in the goat : a simultaneous endo-epicardial mapping study
Eckstein, J. (2012) · doi:10.26481/dis.20120118je · Cited by 3
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling
Krishnamoorthy, S., & Lip, G. Y. H. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02083.x · Cited by 3
Collagen type V, interstitial fibrosis and the substrate for atrial fibrillation
Wagoner, D. R. V. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101356 · Cited by 3
Active Colitis-Induced Atrial Electrophysiological Remodeling
Kittaka, H., Ouille, E. J., Pereira, C. H., Pelaez, A. F., Keshavarzian, A., & Banach, K. (2025) · Biomolecules · doi:10.3390/biom15070982 · Cited by 2
Prevention of Atrial Fibrillation After Atrial Flutter Ablation With Ramipril (from the PREFACE Study)
Guichard, J.-B., Anselme, F., Defaye, P., Mansourati, J., Pavin, D., Pasquié, J., Saludas, Y., Barthélemy, J., Roche, F., Laporte, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.09.010 · Cited by 2
Analyses of m6A regulatory genes and subtype classification in atrial fibrillation
Zhao, Y., Che, Y., Liu, Q., Zhou, S., & Xiao, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1073538 · Cited by 2
The Role of Different Components of Metabolic Syndrome in the Pathogenesis of Atrial Fibrillation
Rafaqat, S., Sharif, S., Murad, M. A., Bibi, F., & Rafaqat, S. (2024) · Journal of Cardiac Arrhythmias · doi:10.24207/jca.v37i1.3501 · Cited by 2
The effect of continuous positive airway pressure therapy on atrial fibrillation in patients with obstructive sleep apnea
Hu, J., Zuo, S., Qian, J., Cheng, F., Wang, D., Deng, Y., & Lu, D. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1509776 · Cited by 3
Thrombogenesis in Atrial Fibrillation
Ahmed, H. M. (2013) · InTech eBooks · doi:10.5772/53613 · Cited by 2
Upstream approach for atrial fibrillation.
Kumagai, K. (2010) · Folia Pharmacologica Japonica · doi:10.1254/fpj.135.59 · Cited by 2
Prevención de la fibrilación auricular en los pacientes con insuficiencia cardiaca
Hernández‐Madrid, A., Moreno, G., Rondón, J., Marín, W. V., Castillo, M., Bernal, O., Tarancón, B., Amador, A., & Moro, C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)75310-9 · Cited by 2
Combined use of calcium channel blockers and inhibitors of the renin–angiotensin system for treating hypertension
Mizuno, Y., Jacob, R. F., & Mason, R. P. (2011) · Therapy · doi:10.2217/thy.11.17 · Cited by 2
Upstream-Therapie bei Vorhofflimmern
Goette, A., Hammwöhner, M., & Bukowska, A. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0303-0 · Cited by 2
Factors for C-Kit Expression in Cardiac Outgrowth Cells and Human Heart Tissue
Matsushita, S., Minematsu, K., Yamamoto, T., Inaba, H., Kuwaki, K., Shimada, A., Yokoyama, Y., & Amano, A. (2017) · International Heart Journal · doi:10.1536/ihj.16-559 · Cited by 2
2018 Korean Heart Rhythm Society Guidelines for Detection and Management of Risk Factors and Concomitant Cardiovascular Diseases in Korean Patients with Atrial Fibrillation
Lee, S.-R., Lee, Y.-S., Lim, W., Kim, T.-H., Cha, M., Lee, J., Baek, Y., Lim, H., Joung, B., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.4.324 · Cited by 2
Atrial fibrillation and kidney disease: insights on a close relationship
Trivioli, G. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02141-0 · Cited by 2
LEFT ATRIUM AND MODERN VIEWS ON PATHOGENESIS OF ESSENTIAL HYPERTENSION
Барсуков, А. В., Владимирович, Г. Д., Zobnina, N. P., Сергеевна, Т. М., & Свеклина, Т. С. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-1-18-26 · Cited by 2
The Pathophysiological Implications of TRP Channels in Cardiac Arrhythmia
Inoue, R., Duan, Y., Yaopeng, H., & Ichikaw, J. (2012) · InTech eBooks · doi:10.5772/32249 · Cited by 2
Genetic determinants of atrial fibrillation: SNPs are riding the wave(lets)
Gollob, M. H. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.04.016 · Cited by 2
ANP and B-type peptide: Twins or kins? A different predictive value in atrial fibrillation
Wożakowska−Kapłon, B. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.08.011 · Cited by 2
New Insights into Molecular Mechanisms of Atrial Fibrillation: Are We Approaching Possible Novel Pharmacological Principles for Treating This Disorder?
Goette, A., & Lendeckel, U. (2003) · Heart Drug · doi:10.1159/000073239 · Cited by 1
Atrial Fibrillation: Antiarrhythmic Therapy
Crijns, H. J. G. M., Gelder, I. C. V., Savelieva, I., & Camm, A. J. (2002) · Wiley eBooks · doi:10.1002/9780470986882.ch37 · Cited by 2
Elektrisches Remodeling bei chronischem Vorhofflimmern des Menschen
Dobrev, D., Wettwer, E., Christ, T., & Ravens, U. (2003) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-003-0379-4 · Cited by 2
Cardiología (ESC) Desarrolladas con la contribución especial de European Heart Rhythm Association (EHRA) Aprobado por European Association for Cardio-Thoracic Surgery (EACTS)
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
Molekularbiologie der Herzvorh�fe
Goette, A., Lendeckel, U., & Klein, H. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0147-4 · Cited by 2
The Pathophysiology of Atrial Fibrillation
Nattel, S. (2001) · Cardiac Electrophysiology Review · doi:10.1023/a:1011420530575 · Cited by 2
Angiotensin-converting enzyme: a well-known stranger. Part II
Олеговна, Н. Е. (2023) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2023-29-6-543-556 · Cited by 1
RASopathies and Cardiac Complications: Insights into Mechanisms, Diagnosis, and Innovative Treatments
Garg, K., Trehan, S., Fredrick, F. C., Singla, A., Aggarwal, K., Gupta, A., & Jain, R. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x341624250324164700 · Cited by 1
NADPH oxidase-dependent reactive oxygen species upregulate KCa3.1 to promote atrial fibroblast activation
Wu, J., Zhu, Y., Wu, Y., Liu, X., Jiang, W., Wang, Y., Wang, Z., Li, M., Liu, L., Zhao, J., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115105 · Cited by 1
Possible Beneficial Effect of??Olmesartan Medoxomil on??Left??Atrial??Function in Patients??with Hypertension
Gong, H., Zhang, W., Li, L., Tan, H., Ma, Z., Zhong, X.-Z., Wang, Z., Song, T., Zhang, Y., & Zhong, M. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828040-00005 · Cited by 1
PPAR-γ activation limits angiotensin II-mediated atrial remodeling: One drug fits all AF patients?
Lendeckel, U., Wolke, C., & Goette, A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.001 · Cited by 1
Atrial Fibrillation Revisited —With a Special Reference to Primary Prevention—
Aizawa, Y., Furushima, H., & Watanabe, H. (2007) · Journal of Arrhythmia · doi:10.1016/s1880-4276(07)80010-x · Cited by 1
Heritability and genetics of atrial fibrillation
Aleong, R. G., MacRae, C. A., & Ellinor, P. T. (2007) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-007-0068-7 · Cited by 1
Angiotensin-(1-7): A new therapeutic strategy in the management of atrial fibrillation
Li, Y., Li, G., & Liu, T. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.12.040 · Cited by 1
Recent Insights into the Mechanisms Underlying Persistent Atrial Fibrillation
Shah, A. J., Pedersen, M., & Hocini, M. (2012) · Cited by 1
Management des Vorhofflimmerns
Hilbert, S., Bode, K., John, S., Kircher, S., Müssigbrodt, A., Dagres, N., & Hindricks, G. (2014) · Der Kardiologe · doi:10.1007/s12181-014-0613-9 · Cited by 1
Neurohormonal Activation and Left Atrium Remodeling in Mitral Stenosis
Rejeki, V. G., Siswanto, B. B., & Hersunarti, N. (2017) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v37i1.555 · Cited by 1
Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?
Schmitt, H., Liang, B. T., & Pickett, C. C. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.753 · Cited by 1
Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden
Dan, G. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100610 · Cited by 1
Prevalence of Hyperthyroidism in Patients with Atrial Fibrillation
Ullah, I., Ghaffar, S., Ilyas, M., Zeb, F., Tahir, S., & Zaman, M. H. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221610869 · Cited by 1
The surface-enhanced Raman scattering method for point-of-care atrial fibrillation diagnostics
Boginskaya, I. A., Safiullin, R. R., Tikhomirova, V. E., Kryukova, O. V., Afanasev, K., Efendieva, A. T., Bulaeva, N. I., Golukhova, E. Z., Ryzhikov, I. A., Kost, O. A., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109923 · Cited by 1
Elektrophysiologie und Pathophysiologie von Vorhofflimmern
Goette, A., Lendeckel, U., & Klein, H. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1748-6_4 · Cited by 1
Relationship between peculiarities of atrial fibrillation, body mass index and adipokines levels
Бiловол, О. М., Shaposhnikova, Y., Ilchenko, I., & Shalimova, A. (2017) · Vessel Plus · doi:10.20517/2574-1209.2017.17 · Cited by 1
ГУМАНИЗАЦИЯ МЫШИНЫХ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ПРОТИВ HTNF: ИСТОРИЯ ГИБРИДОМЫ F10#, "Молекулярная биология"
Efimov, G. A., Raats, J. M. H., Chirivi, R. G. S., van, R. J. W. G., & Недоспасов, С. А. (2017) · Molecular Biology · doi:10.7868/s0026898417060167 · Cited by 1

Authors: Goette, A., Staack, T., Röcken, C., Arndt, M., Geller, J. C., Huth, C., Ansorge, S., Klein, H. U., & Lendeckel, U.
Affiliations: University Hospital Magdeburg (DE)
Corresponding author: Goette, Andreas
ORCID: Goette, Andreas
Staack, Thorsten
Röcken, Christoph
Arndt, Marco
Geller, J.Christoph
Klein, Helmut U
Lendeckel, Uwe
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2000-05
Volume: 35
Issue: 6
Pages: 1669-1677
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/s0735-1097(00)00611-2
OpenAlex: W2038843437
Cited by: 583
References: 47
Citations by year: 2026: 5 · 2025: 8 · 2024: 14 · 2023: 10 · 2022: 17 · 2021: 17 · 2020: 15 · 2019: 17 · 2018: 10 · 2017: 17 · 2016: 20 · 2015: 17 · 2014: 23 · 2013: 24 · 2012: 27
FWCI: 10.88
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4824 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: atrial fibrillation, extracellular signal-regulated kinase, ERK1/ERK2, angiotensin-converting enzyme, atrial fibrosis, MEK1/2, interstitial cells, chronic atrial fibrillation, paroxysmal atrial fibrillation, ACE inhibitors, MAPK signaling
MeSH terms: Aged, Atrial Fibrillation, Endomyocardial Fibrosis, Female, Heart Atria, Humans, Peptidyl-Dipeptidase A, Male, Middle Aged, RNA, Messenger, Gene Expression Regulation, Enzymologic, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks